Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory Board to Advance Innovation
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Hypertrophic Cardiomyopathy (HCM) Medical Advisory Board to assist the company in the development of strategy and products to support cardiologists and improve patient care.